Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.37%12.49M | 8.09%44.14M | 2.16%10.31M | 17.34%11.83M | 11.21%11.36M | 1.87%10.64M | -10.32%40.84M | -3.69%10.09M | -8.73%10.08M | -14.87%10.22M |
| Cost of revenue | 8.86%5.13M | 14.03%19.85M | -11.44%4.41M | 43.37%5.45M | 35.45%5.23M | 19.68%4.71M | 29.13%17.4M | 105.65%4.97M | -8.67%3.8M | 6.71%3.86M |
| Gross profit | 24.13%7.36M | 3.67%24.29M | 15.38%5.91M | 1.58%6.38M | -3.52%6.13M | -8.89%5.93M | -26.90%23.43M | -36.50%5.12M | -8.78%6.28M | -24.20%6.35M |
| Operating expense | -20.45%3.06M | 7.86%14.88M | -0.20%4.7M | -23.85%2.63M | 16.74%3.69M | 4.96%3.85M | -2.19%13.79M | 27.71%4.71M | 6.69%3.45M | -14.38%3.16M |
| Selling and administrative expenses | -19.69%2.99M | 10.82%14.28M | 17.55%3.53M | -9.71%2.93M | 17.27%3.21M | 24.43%3.73M | -5.77%12.89M | -28.64%3M | 10.99%3.25M | -19.14%2.74M |
| -Selling and marketing expense | -35.06%959.56K | 15.06%5.93M | 142.18%1.64M | -21.68%1.35M | 17.45%1.46M | -2.02%1.48M | -17.24%5.16M | -55.32%677.25K | 25.08%1.73M | -28.04%1.25M |
| -General and administrative expense | -9.59%2.03M | 7.99%8.35M | -18.72%1.89M | 3.86%1.58M | 17.13%1.75M | 51.24%2.25M | 3.83%7.73M | -13.62%2.33M | -1.58%1.52M | -9.84%1.49M |
| Research and development costs | ---- | 132.01%598.18K | ---- | ---- | ---- | ---- | 13.27%257.83K | ---- | ---- | ---- |
| Other operating expenses | -43.99%67.6K | 178.47%1.81M | -31.54%1.17M | ---- | 13.25%478.79K | -82.01%120.69K | 223.95%650K | 326.30%1.7M | -34.18%203.12K | 38.45%422.77K |
| Total other operating income | ---- | ---- | ---- | --304.75K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 106.45%4.3M | -2.32%9.41M | 193.14%1.21M | 32.65%3.75M | -23.57%2.44M | -26.73%2.08M | -46.31%9.64M | -90.58%412.48K | -22.49%2.83M | -31.92%3.19M |
| Net non-operating interest income (expenses) | -45.70%144.06K | -16.48%265.32K | ||||||||
| Non-operating interest income | ---- | -45.70%144.06K | ---- | ---- | ---- | ---- | -16.48%265.32K | ---- | ---- | ---- |
| Net investment income | -35.15%71.37K | -86.08%110.06K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 28.49%289.89K | -28.20%637.67K | -76.07%200.9K | -24.51%197K | -45.15%263.57K | -25.37%225.61K | 27.08%888.13K | 190.53%839.64K | 5.20%260.95K | -50.35%480.49K |
| Income before tax | 98.84%4.59M | -5.82%10.27M | 12.61%1.41M | 27.82%3.95M | -26.39%2.7M | -26.60%2.31M | -44.83%10.9M | -72.53%1.25M | -20.73%3.09M | -35.08%3.67M |
| Income tax | 92.67%1.14M | -16.43%2.54M | -41.30%367.2K | -20.55%989.97K | 11.92%686.88K | 7.70%590.93K | -36.37%3.03M | -41.13%625.52K | 30.10%1.25M | -55.43%613.71K |
| Net income | 100.95%3.45M | -1.72%7.73M | 66.43%1.04M | 60.54%2.96M | -34.08%2.02M | -33.84%1.72M | -47.52%7.87M | -82.07%626.6K | -37.30%1.84M | -28.53%3.06M |
| Net income continuous operations | 100.95%3.45M | -1.72%7.73M | 66.43%1.04M | 60.54%2.96M | -34.08%2.02M | -33.84%1.72M | -47.52%7.87M | -82.07%626.6K | -37.30%1.84M | -28.53%3.06M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 100.95%3.45M | -1.72%7.73M | 66.43%1.04M | 60.54%2.96M | -34.08%2.02M | -33.84%1.72M | -47.52%7.87M | -82.07%626.6K | -37.30%1.84M | -28.53%3.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 100.95%3.45M | -1.72%7.73M | 66.43%1.04M | 60.54%2.96M | -34.08%2.02M | -33.84%1.72M | -47.52%7.87M | -82.07%626.6K | -37.30%1.84M | -28.53%3.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 100.00%0.0108 | -1.62%0.0243 | 65.00%0.0033 | 60.34%0.0093 | -33.68%0.0063 | -34.15%0.0054 | -47.45%0.0247 | -81.65%0.002 | -37.63%0.0058 | -29.63%0.0095 |
| Diluted earnings per share | 100.00%0.0108 | -1.62%0.0243 | 65.00%0.0033 | 60.34%0.0093 | -33.68%0.0063 | -34.15%0.0054 | -47.45%0.0247 | -81.65%0.002 | -36.96%0.0058 | -29.10%0.0095 |
| Dividend per share | 0.016 | 0.00%0.0125 | 0 | 0 | 0.00%0.0125 | 0 | -40.48%0.0125 | 0 | 0 | 0.00%0.0125 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.